multipl
sclerosi
ms
rel
common
etiolog
unknown
diseas
cure
lead
caus
neurolog
disabl
young
adult
affect
two
million
peopl
worldwid
tradit
ms
consid
chronic
inflammatori
disord
central
white
matter
ensu
demyelin
result
physic
disabl
recent
ms
becom
increasingli
view
neurodegen
disord
axon
injuri
neuron
loss
atrophi
central
nervou
system
lead
perman
neurolog
clinic
disabl
articl
discuss
latest
develop
ms
research
includ
etiolog
patholog
genet
associ
eae
anim
model
mechan
neuron
injuri
axon
transport
therapeut
articl
also
focu
mechan
mitochondri
dysfunct
involv
ms
includ
mitochondri
dna
defect
mitochondri
structuralfunct
chang
multipl
sclerosi
ms
chronic
potenti
highli
disabl
disord
consider
social
impact
econom
consequ
onset
ms
typic
occur
earli
adulthood
make
ms
common
neurolog
diseas
affect
peopl
age
major
caus
nontraumat
disabl
young
adult
social
cost
associ
ms
high
earli
age
onset
patient
ms
experi
earli
loss
product
need
assist
perform
activ
daili
live
requir
immunomodulatori
treatment
multidisciplinari
health
care
current
nearli
peopl
live
ms
unit
state
least
patient
ms
unit
state
clinic
present
ms
heterogen
main
symptom
includ
impair
vision
extrem
fatigu
spasm
paralysi
varieti
muscl
system
major
case
ms
develop
episod
fashion
phase
clinic
diseas
follow
recoveri
form
ms
call
relapsingremit
ms
rrm
white
matter
lesion
typic
deterior
perman
tissu
injuri
associ
neural
loss
clinic
disabl
time
rrm
patient
may
develop
chronic
lesion
promot
irrevers
axon
injuri
result
convers
rrm
secondari
progress
ms
spm
spm
character
minim
intermitt
recoveri
function
cognit
impair
also
common
ms
occur
stage
diseas
progress
dysfunct
free
recal
longterm
memori
speed
inform
process
work
memori
abstract
reason
frequent
observ
ms
recent
year
basic
research
ms
elucid
mechan
process
underli
diseas
develop
imag
techniqu
magnet
reson
imag
mri
develop
immunomodulatori
drug
first
time
alter
diseas
outcom
howev
basic
research
ms
help
explain
mani
disord
associ
ms
depress
frequent
psychiatr
disord
ms
patient
caus
depress
multifactori
like
associ
psychosoci
stress
focal
demyelin
lesion
immun
dysfunct
earli
intervent
depress
prevent
declin
qualiti
life
typic
character
ms
patient
even
prevent
suicid
despit
advanc
reduc
clinic
symptom
patient
ms
use
immunomodul
pharmacotherapi
respond
well
treatment
especi
patient
spm
probabl
due
diseas
heterogen
multiloc
multicel
damag
throughout
white
matter
also
gray
matter
central
nervou
system
cn
gray
matter
involv
detect
earliest
stage
ms
cortic
gray
matter
atrophi
found
occur
faster
rate
white
matter
atrophi
earli
diseas
progress
suggest
mechan
may
involv
ms
develop
progress
hypothesi
challeng
current
research
ms
focus
white
matter
deni
confirm
hypothesi
addit
research
need
argu
develop
new
approach
therapi
purpos
articl
review
latest
develop
ms
research
particularli
causal
factor
therapeut
approach
review
mechan
mitochondri
functiondysfunct
includ
mitochondri
dna
defect
mitochondri
structur
function
chang
mitochondri
dna
repair
event
mitochondri
therapeut
involv
ms
patient
eae
mous
model
date
exact
caus
ms
still
unclear
believ
result
abnorm
respons
immun
system
one
myelin
antigen
develop
genet
suscept
individu
exposur
asyet
undefin
causal
agent
character
accumul
macrophag
microglia
brain
lymphocyt
cn
white
matter
gray
matter
lead
demyelin
destruct
axon
fig
summar
possibl
causal
factor
ms
identif
character
ms
suscept
gene
like
defin
basic
etiolog
diseas
improv
risk
assess
influenc
therapi
past
year
seen
progress
defin
genet
basi
ms
increas
risk
occurr
within
famili
indic
genet
factor
may
play
role
ms
etiolog
ms
like
strike
sibl
gener
popul
like
strike
monozygot
compar
dizygot
twin
recent
whole
genom
screen
conduct
differ
popul
identifi
discret
chromosom
region
potenti
harbor
ms
suscept
gene
howev
except
major
histocompat
complex
mhc
singl
locu
gener
overwhelm
evid
genet
linkag
result
suggest
complex
genet
etiolog
ms
includ
multipl
gene
small
moder
effect
probabl
genet
heterogen
hand
human
leukocyt
antigen
hla
found
control
immun
respons
gene
ms
hla
associ
indic
involv
autoimmun
ms
one
first
diseas
proven
hlaassoci
primarili
link
hla
class
ii
factor
molecul
may
explain
ms
case
furthermor
protein
tyrosin
phosphatas
receptortyp
c
ptprc
report
candid
famili
ms
ptprc
polymorph
present
preferenti
transmit
small
subgroup
ms
famili
may
detect
complementari
method
analysi
recent
larg
intern
research
collabor
provid
strong
evid
involv
polymorph
two
cytokin
receptor
gene
ms
pathogenesi
interleukin
receptor
alpha
chain
gene
chromosom
interleukin
receptor
alpha
chain
gene
chromosom
estim
c
allel
singlenucleotid
polymorph
within
altern
splice
exon
involv
ms
case
investig
indic
ms
strong
genet
compon
interestingli
find
confirm
recent
pathway
networkbas
genomewid
associ
studi
gwa
gwa
neural
pathway
name
axon
guidanc
synapt
potenti
also
overrepres
gene
ms
patient
addit
identifi
immunolog
pathway
previous
identifi
first
time
gwa
describ
potenti
involv
neural
pathway
ms
suscept
exampl
gwa
reveal
comprehens
extens
immun
antigen
cell
adhes
signal
molecul
associ
ms
well
glutam
receptor
multimer
scaffold
molecular
use
poolingbas
genomewid
approach
highdens
singlenucleotid
polymorph
array
gwa
also
identifi
novel
risk
locu
ms
chromosom
addit
hla
class
ii
gene
longstand
hypothesi
ms
etiolog
ms
infecti
diseas
microorgan
howev
decad
research
specif
infecti
agent
identifi
ms
yet
mani
neurologist
research
still
remain
open
infecti
origin
ms
particular
much
interest
focus
potenti
role
epsteinbarr
viru
ebv
recent
find
populationbas
investig
support
implic
ebv
ms
suscept
report
clinic
histori
infecti
mononucleosi
conspicu
associ
increas
ms
suscept
studi
progress
ms
case
found
ebv
present
within
b
cell
infiltr
mening
membran
envelop
cn
white
matter
strong
evid
involv
ebv
ms
b
cell
trigger
anoth
type
viru
corona
virus
also
found
brain
ms
patient
corona
virus
import
human
anim
pathogen
order
nidoviral
usual
caus
respiratori
gastrointestin
ill
includ
sar
sever
acut
respiratori
syndrom
howev
locat
brain
ms
patient
indic
may
possibl
ms
pathogen
neurotrop
immun
system
attack
virus
found
induc
demyelin
diseas
anim
virus
induc
demyelin
diseas
anim
strongli
support
hypothesi
ms
may
viral
origin
femal
caucasian
peopl
northern
european
ancestri
increas
risk
ms
incid
ms
person
fig
factor
may
contribut
develop
progress
multipl
sclerosi
precis
causal
factor
multipl
sclerosi
unknown
howev
possibl
multipl
factor
involv
caus
multipl
sclerosi
includ
dna
defect
nuclear
mitochondri
genom
viral
infect
hypoxia
oxid
stress
lack
sunlight
suffici
level
vitamin
increas
macrophag
lymphocyt
brain
ancestri
consider
increas
last
centuri
increas
greatest
women
larg
multicent
clinic
trial
glatiram
acet
primari
progress
multipl
sclerosi
indic
exist
differ
rate
clinic
diseas
men
women
ms
sex
dimorph
ms
may
explain
effect
sex
chromosom
sex
steroid
hormon
immun
system
bloodbrain
barrier
parenchym
cn
cell
clinic
experiment
studi
found
sex
steroid
supplement
may
benefici
ms
patient
order
reduc
symptom
interestingli
benefici
neuroprotect
effect
ms
note
clinic
studi
elev
level
hormon
femal
male
hormon
estrogen
progesteron
androgen
elev
could
relat
antiinflammatori
action
immun
system
cn
relat
direct
neuroprotect
properti
mention
action
also
seen
estrogen
receptor
regul
anim
model
observ
may
stimul
current
clinic
studi
determin
efficaci
toler
sex
steroid
therapeut
approach
ms
well
relat
diseas
interestingli
genderbas
method
use
sexspecif
genotypespecif
primari
cultur
recent
establish
astrocyt
main
type
glial
cell
show
sex
differ
oxygenglucos
depriv
ogd
wildtyp
femal
astrocyt
resist
ogd
wildtyp
male
cell
sex
differ
disappear
aromatas
knockout
cell
combin
data
suggest
critic
role
androgenaromataseestrogen
network
protect
cell
stress
condit
howev
sex
differ
oligodendrocyt
anoth
glial
cell
origin
target
ms
report
therefor
sexspecif
oligodendrocyt
studi
may
help
understand
role
gender
differ
ms
etiolog
ms
therapeut
preval
ms
higher
scandinavia
iceland
british
isl
north
america
per
southern
europ
notabl
except
sardinia
accord
observ
geograph
distribut
implic
environment
diseas
pathogen
may
ubiquit
distribut
howev
geograph
distribut
ms
might
also
explain
least
part
region
variat
genet
risk
factor
interestingli
residenti
occup
exposur
ms
patient
sunlight
may
associ
lower
mortal
rate
ms
slower
progress
vitamin
mediat
effect
sinc
ultraviolet
radiat
princip
catalyst
endogen
vitamin
synthesi
human
low
level
vitamin
common
northern
latitud
southern
latitud
may
anoth
reason
person
southern
european
countri
lower
rate
ms
proinflammatori
cytokin
interferon
tumor
necrosi
factor
beta
releas
activ
cell
may
upregul
express
cellsurfac
molecul
neighbor
lymphocyt
antigenpres
cell
apc
bind
put
ms
antigen
may
trigger
enhanc
immun
respons
bound
antigen
put
ms
antigen
includ
compon
myelin
myelin
basic
protein
mbp
myelinassoci
basic
glycoprotein
myelin
oligodendrocyt
glycoprotein
mog
proteolipid
protein
plp
other
trimolecular
complex
cell
receptor
major
histocompat
complex
class
ii
molecul
apc
may
trigger
either
enhanc
immun
respons
bound
antigen
addit
autoimmun
respons
oligodendrocyt
death
axon
damag
even
neuron
loss
also
associ
ms
inflammatori
attack
cn
howev
reason
attack
larg
unknown
although
genet
factor
may
influenc
immunemedi
inflamm
well
neuron
glial
surviv
modul
ms
phenotyp
therefor
autoreact
cell
thought
gener
respons
interplay
environment
trigger
genet
suscept
factor
differenti
cell
result
proinflammatori
cell
andor
regulatori
cell
produc
cytokin
interferongamma
activ
myelinspecif
cell
abl
cross
bloodbrain
barrier
via
interact
adhes
molecul
vascular
cell
adhes
cn
includ
cerebr
cortex
reactiv
cell
involv
local
apc
apc
initi
detriment
cascad
typic
involv
attract
microglia
macrophag
cell
plasma
cell
produc
myelinspecif
antibodi
may
ms
tier
mechan
combin
may
lead
mitochondri
dysfunct
neuron
demyelin
irrevers
tissu
damag
character
axon
loss
gliosi
recent
evid
show
myelinspecif
cell
also
recogn
neuron
autoantigen
mous
model
ms
indic
multipl
autoantigen
may
involv
spontan
develop
human
ms
diseas
featur
tissu
damag
found
brain
spinal
cord
tissu
classic
ms
lesion
term
reactiv
lesion
howev
recent
new
concept
term
preactiv
lesion
use
refer
earli
patholog
chang
occur
actual
develop
reactiv
activ
demyelin
lesion
inde
focal
disord
document
normalappear
white
matter
ms
patient
month
year
appear
gadoliniumenhanc
lesion
cluster
activ
microglia
cell
identifi
lesion
mri
immunohistochemistri
notabl
absenc
demyelin
clear
leukocyt
infiltr
distinguish
tradit
demyelin
activ
lesion
chronic
activ
lesion
preactiv
lesion
also
seen
gray
matter
particularli
part
may
variabl
degre
demyelin
along
region
eventu
becom
overtli
lesion
contain
area
remyelin
activ
state
microglia
cell
also
reflect
increas
express
human
leukocyt
antigendr
hladr
addit
foami
macrophag
occasion
found
cluster
togeth
featur
strongli
suggest
progress
ms
may
includ
stage
actual
preced
term
tradit
reactiv
ms
lesion
although
event
give
rise
preactiv
lesion
still
identifi
oligodendrocyt
abnorm
appear
crucial
involv
importantli
preactiv
lesion
alway
develop
demyelin
lesion
therefor
preactiv
lesion
ms
may
repres
earli
stage
develop
ms
lesion
mani
spontan
resolv
expect
hold
import
clue
halt
inflammatori
demyelin
process
ms
activ
proinflammatori
mechan
microglia
may
favour
diseas
progress
upregul
gene
involv
antiinflammatori
antioxid
mechan
driven
oligodendrocyt
astrocyt
may
protect
cn
environ
thu
limit
lesion
format
interestingli
dysfunct
mitochondria
lesion
well
normalappear
white
gray
matter
increasingli
recogn
ms
could
import
determin
axon
dysfunct
degener
togeth
observ
indic
mitochondria
mitochondrialtarget
antioxid
agent
may
potenti
diseas
addit
antiinflammatori
intracellular
environ
especi
ionic
balanc
critic
maintain
neuron
function
ionic
imbal
hypothes
key
mechan
ms
pathophysiolog
progress
ms
inflammatori
mediat
includ
cytokin
oxid
nitric
oxid
releas
microglia
gener
hypoxia
secondari
tissu
damag
believ
result
malfunct
oxid
metabol
demyelin
axon
mediat
deplet
atp
perturb
mitochondri
function
caus
failur
na
k
atpas
enzym
respons
rapidli
correct
na
k
level
extrud
na
axon
prevent
patholog
influx
na
rest
activ
axon
hypoxia
consid
physiolog
stress
induc
replicationassoci
dna
damag
respons
shown
hypoxia
inhibit
na
k
atpas
activ
ro
increas
na
k
atpas
degrad
even
normalappear
white
matter
ms
microarray
analysi
reveal
transcript
factor
key
regul
hypoxiainduc
gene
regul
downstream
gene
significantli
consist
upregul
indic
hypoxia
condit
area
shown
studi
anoxia
high
intraaxon
na
concentr
result
failur
caus
increas
activ
na
ca
exchang
channel
efflux
na
requir
higher
degre
ca
influx
turn
activ
intraaxon
proteas
result
neurofila
fragment
perturb
axon
transport
integr
ultim
lead
neuron
degener
fact
na
k
atpas
enzymat
activ
distribut
reduc
undetect
chronic
ms
patient
appear
chronic
demyelin
axon
lack
na
k
atpas
exchang
axoplasm
na
k
incap
nerv
transmiss
therefor
loss
axon
na
k
atpas
like
major
contributor
continu
neurolog
declin
chronic
stage
ms
experiment
model
demyelin
diseas
age
anim
well
multipl
sclerosi
oligodendrocyt
precursor
cell
opc
differenti
appear
impair
due
least
part
chang
environment
signal
govern
remyelin
particular
myelin
debri
within
lesion
appear
contain
power
inhibitor
precursor
cell
differenti
shown
glycosaminoglycan
hyaluronan
ha
accumul
demyelin
lesion
patient
ms
mice
eae
ha
prevent
remyelin
inhibit
opc
matur
effici
remov
molecul
myelin
debri
macrophag
microglia
function
system
may
thu
facilit
opc
differenti
permit
success
remyelin
damag
axon
interestingli
elimin
myelin
debri
extrem
effici
young
anim
wherea
old
anim
show
poor
clearanc
myelin
debri
system
progesteron
administr
could
revers
partial
ageassoci
declin
cn
remyelin
male
rat
observ
indic
inhibitor
remyelin
increas
andor
clearanc
system
effici
age
anim
steroid
hormon
tissueneurotroph
factor
may
involv
process
identifi
signal
molecul
network
myelin
sheath
myelin
debri
probabl
repres
promis
therapeut
target
pharmacolog
strategi
aim
enhanc
remyelin
autophagi
newli
recogn
cellular
function
system
deliv
cytoplasm
materi
lysosom
degrad
format
autophagosom
control
specif
set
autophagyrel
gene
call
atg
gene
autophagi
thought
major
evolutionarili
conserv
respons
nutrient
bioenerget
stress
autophagi
hypothes
remov
aggreg
protein
damag
organel
mitochondria
recent
studi
provid
evid
autophagi
anoth
mechan
program
cell
death
term
autophag
program
cell
death
secondari
program
cell
death
distinguish
apoptosi
therebi
possess
import
housekeep
qualitycontrol
function
contribut
health
longev
autophagi
also
play
role
innat
adapt
immun
apoptosi
neurodegener
age
well
prevent
cancer
howev
excess
imbalanc
induct
autophag
recycl
activ
contribut
neuron
atrophi
neurit
degener
cell
death
role
autophagi
cell
recent
examin
mous
cell
interestingli
rest
naiv
cell
contain
detect
autophagosom
autophagi
observ
activ
cell
upon
tcr
stimul
cytokin
cultur
prolong
serum
starvat
induct
autophagi
cell
requir
jnk
class
iii
autophagi
inhibit
caspas
mammalian
target
rapamycin
cell
cell
cell
undergo
autophagi
cell
becom
resist
growth
factorwithdraw
cell
death
autophagi
block
use
either
chemic
inhibitor
rna
interfer
knockdown
beclin
therefor
autophagi
import
mechan
control
homeostasi
cell
recent
alirezaei
et
al
examin
express
gene
cell
use
mous
model
autoimmun
demyelin
well
blood
brain
tissu
ms
patient
quantit
realtim
pcr
analysi
rna
isol
blood
sampl
experiment
autoimmun
enceph
eae
mice
reveal
strong
correl
express
clinic
disabl
analysi
protein
extract
cell
confirm
upregul
posttransl
modif
gene
latter
posit
correl
eae
sever
analysi
rna
extract
cell
isol
neg
select
indic
express
significantli
elev
patient
activ
rrm
compar
nondiseas
control
brain
tissu
section
rrm
patient
examin
immunofluoresc
histochemistri
suggest
encephalitogen
cell
may
sourc
express
ms
brain
togeth
data
suggest
increas
cell
express
may
contribut
inflammatori
demyelin
ms
anoth
clearanc
machineri
ubiquitinproteasom
system
up
destruct
protein
import
synthesi
mainten
protein
homeostasi
cell
eukaryot
ubiquitinproteasom
system
respons
protein
degrad
small
protein
ubiquitin
act
death
warrant
tag
target
protein
larg
proteolyt
chamber
proteasom
known
ubiquitinmedi
destruct
play
crucial
part
mani
basic
cell
function
given
central
role
up
divers
cellular
process
surpris
dysfunct
contribut
neurodegen
immunolog
disord
either
primari
caus
secondari
consequ
importantli
proteolysi
system
atpdepend
recent
shown
assembl
proteasom
base
rapid
yet
highli
orchestr
process
proteasom
regulatori
particl
chaperonemedi
autoimmun
process
relaps
experiment
autoimmun
encephalomyel
regul
part
transcript
factor
nuclear
factor
nf
kappab
activ
via
up
administr
select
inhibitor
ubiquitinproteasom
pathway
remiss
phase
ms
follow
acut
attack
effect
significantli
reduc
incid
clinic
relaps
cn
histopatholog
cell
respons
initi
relapseassoci
plp
epitop
inhibit
clinic
diseas
depend
continu
administr
recoveri
cell
function
onset
diseas
relaps
develop
within
day
drug
withdraw
data
indic
up
involv
relaps
eae
suggest
target
up
particular
nfkappab
may
offer
novel
efficaci
approach
decreas
progress
autoimmun
diseas
includ
ms
proteinas
may
involv
proteolysi
immun
antigen
may
involv
progress
ms
gener
accept
process
mhc
antigen
mediat
up
pathway
addit
matrix
metalloproteinas
proteolysi
play
signific
role
fragment
mbp
classic
mbp
isoform
predominantli
express
oligodendrocyt
cn
recent
vitro
cleavag
studi
determin
mbp
splice
variant
highli
sensit
redund
matrix
metalloproteinas
proteolysi
initi
call
leukolysin
howev
superior
mmp
cleav
mbp
isoform
studi
demonstr
matrix
metalloproteinas
proteolysi
mbp
isoform
sourc
immunogen
peptid
autoimmun
ms
case
vivo
case
matrix
metalloproteinas
proteolysi
may
directli
destroy
mbp
initi
demyelin
ms
eae
proteaseactiv
receptor
g
proteincoupl
receptor
regul
cellular
respons
extracellular
serin
proteas
par
famili
consist
four
member
thrombin
receptor
trypsintryptas
receptor
four
member
abundantli
express
brain
throughout
develop
ms
express
par
brain
differenti
upregul
downregul
patholog
condit
neurodegen
disord
includ
ms
noorbakhsh
et
al
found
express
significantli
increas
astrocyt
infiltr
macrophag
human
ms
murin
eae
cn
white
matter
inde
wildtyp
mice
show
markedli
greater
microgli
activ
lymphocyt
infiltr
accompani
worsen
demyelin
axon
injuri
cn
compar
knockout
litterm
enhanc
neuropatholog
chang
associ
sever
progress
relaps
diseas
phenotyp
wildtyp
mice
studi
reveal
pathogen
interact
cn
express
neuroinflamm
ensu
demyelin
axon
injuri
therefor
par
capabl
mediat
either
neurodegener
neuroprotect
ms
well
neurodegen
disord
repres
attract
therapeut
target
treatment
diseas
current
genet
engin
mous
model
avail
studi
ms
progress
mice
howev
sever
induc
mous
model
gener
particularli
eae
mous
eae
induc
immun
suscept
anim
number
myelin
antigen
includ
myelin
basic
protein
plp
mog
origin
eae
date
back
koritschon
schweinburg
induc
spinal
cord
inflamm
rabbit
inocul
tissu
human
spinal
cord
sinc
eae
develop
mani
differ
speci
includ
rodent
primat
eae
anim
model
ms
exhibit
function
characterist
human
immun
molecul
vivo
human
ms
anim
model
allow
function
character
human
immun
molecul
vivo
emphas
mog
although
minor
compon
myelin
sheath
potent
encephalitogen
protein
induc
eae
mani
strain
speci
experiment
anim
particularli
monkey
model
ms
may
close
mimic
human
diseas
may
provid
uniqu
experiment
platform
understand
mechan
diseas
process
also
develop
therapeut
strategi
ms
clear
eae
mimic
mani
clinic
neuropatholog
immunolog
aspect
ms
particular
eae
appear
mimic
close
disabilityrel
axon
loss
seen
ms
may
provid
conveni
opportun
studi
axondamag
mechan
relev
ms
importantli
eae
led
directli
develop
three
therapi
approv
use
ms
glatiram
acet
copaxon
mitoxantron
natalizumab
sever
new
approach
studi
ms
clinic
trial
also
base
preclin
work
reli
eae
limit
use
eae
research
model
ms
first
ms
spontan
diseas
eae
induc
activ
sensit
brain
tissu
antigen
strong
immun
adjuv
second
genet
heterogen
ms
human
popul
understand
diseas
progress
patholog
ms
mice
import
studi
multipl
mous
model
eae
may
provid
human
ms
featur
therefor
use
appropri
eae
model
provid
crucial
tool
improv
understand
treatment
ms
contrast
compel
ms
vitro
model
develop
thu
far
howev
relat
system
report
mseae
mechan
studi
degre
use
oligodendrocyt
neuron
cocultur
microgli
cell
axon
loss
occur
ms
respons
perman
disabl
character
later
chronic
progress
stage
diseas
immunohistochemistri
brain
tissu
show
express
amyloid
precursor
protein
sensit
marker
axon
damag
occur
axon
within
acut
ms
lesion
activ
border
less
acut
lesion
identifi
ms
recent
evid
widespread
axon
damag
even
earliest
clinic
stage
ms
report
lead
hypothesi
ms
neurodegen
disord
axon
injuri
neuron
loss
atrophi
cn
begin
earliest
stage
diseas
intensifi
time
even
axon
loss
could
found
normalappear
white
matter
patient
acut
ms
evid
call
question
previous
longheld
hypothesi
axon
patholog
endstag
result
repeat
inflammatori
event
ms
argu
strongli
favor
earli
neuroprotect
intervent
axon
loss
also
found
anim
model
ms
especi
eae
model
found
correl
perman
neurolog
disabl
anim
model
chronicrelaps
eae
model
provid
excel
platform
two
critic
research
object
determin
mechan
axon
loss
ms
evalu
efficaci
neuroprotect
therapi
fig
summar
involv
mitochondri
abnorm
patient
ms
eae
mous
model
shown
current
research
reveal
follow
mitochondri
abnorm
involv
develop
progress
multipl
sclerosi
mitochondri
dna
defect
abnorm
mitochondri
gene
express
defect
mitochondri
enzym
activ
defici
mitochondri
dna
repair
activ
mitochondri
dysfunct
propos
abnorm
mitochondri
dynam
increas
fission
decreas
fusion
neuron
affect
ms
also
propos
mitochondri
abnorm
mitochondri
energi
failur
may
impact
cellular
pathway
includ
increas
demyelin
inflamm
neuron
tissu
affect
multipl
sclerosi
detail
given
mitochondria
contain
respiratori
chain
energi
form
atp
effici
produc
mitochondri
respiratori
chain
locat
inner
mitochondri
membran
consist
five
complex
complex
iv
fifth
complex
directli
involv
atp
synthesi
complex
mitochondri
respiratori
chain
made
multipl
subunit
contain
protein
encod
nuclear
dna
mtdna
except
complex
ii
entir
encod
nuclear
dna
neuron
highli
depend
oxid
energi
metabol
axon
particular
consum
signific
amount
atp
use
primarili
fuel
sodiumpotassium
atpas
sodium
pump
function
remov
sodium
ion
enter
axon
impuls
activ
mitochondria
energi
factori
cell
also
seat
number
import
cellular
function
includ
essenti
pathway
intermedi
metabol
amino
acid
biosynthesi
fatti
acid
oxid
steroid
metabol
calcium
handl
apoptosi
key
import
role
mitochondria
oxid
energi
metabol
oxid
phosphoryl
gener
cell
atp
impair
organel
abil
produc
energi
catastroph
consequ
due
primari
loss
atp
also
due
indirect
impair
downstream
event
moreov
product
superoxid
occur
mostli
within
mitochondria
mainli
complex
iii
tca
cycl
condit
complex
ii
defici
mitochondri
metabol
may
gener
reactiv
oxygen
speci
ro
wreak
havoc
cell
therefor
mitochondri
dysfunct
attract
candid
neuron
degener
impair
mitochondri
energi
metabol
key
pathogen
factor
number
neurodegen
disord
alzheim
diseas
parkinson
diseas
henc
therapeut
approach
target
mitochondri
dysfunct
oxid
damag
neurodegen
diseas
includ
ms
great
promis
recent
sever
line
evid
suggest
mitochondri
dysfunct
present
patient
ms
mitochondri
dna
alter
mitochondri
structur
chang
defect
mitochondri
dna
repair
event
abnorm
mitochondri
enzym
activ
mitochondri
gene
express
increas
free
radic
product
oxid
damag
report
patient
ms
eae
mous
model
fig
agerel
declin
mtdna
copi
number
associ
lateonset
ms
mtdna
mutat
may
increas
risk
ms
snp
analysi
shown
genet
variant
complex
gene
may
influenc
respons
tissu
inflamm
cn
genet
alter
uncoupl
protein
report
implic
patient
ms
uncoupl
protein
member
mitochondri
proton
transport
famili
uncoupl
proton
entri
mitochondria
atp
synthesi
vogler
et
al
report
common
promot
polymorph
associ
suscept
ms
german
popul
studi
ms
patient
control
subject
found
common
g
allel
associ
diseas
suscept
p
allel
correl
lower
level
express
vitro
vivo
thu
may
contribut
ms
suscept
regul
level
protein
cn
andor
immun
system
defect
mtdna
associ
lateonset
ms
ban
et
al
sequenc
mtdna
patient
ms
complet
haplogroup
analysi
ms
patient
control
found
trend
toward
overrepresent
superhaplogroup
u
evid
associ
ms
parallel
analysi
nuclearencod
mitochondri
protein
gene
subject
also
found
trend
toward
associ
complex
gene
taken
togeth
studi
contribut
evid
suggest
variat
mtdna
nuclearencod
mitochondri
protein
gene
may
contribut
diseas
suscept
ms
studi
ms
patient
europ
show
potenti
function
mtdna
snp
ga
significantli
associ
increas
risk
ms
p
studi
identifi
variant
allel
suscept
ms
may
suggest
role
ms
pathogenesi
recent
vyshkina
et
al
discov
associ
among
common
variant
mitochondri
gene
ms
system
lupu
erythematosu
find
rais
possibl
share
mitochondri
genet
background
two
autoimmun
diseas
hand
increas
number
case
report
leber
hereditari
optic
neuropathi
lhon
associ
mtdna
point
mutat
patient
ms
lhon
share
mtdna
mutat
suggest
mitochondri
determin
may
contribut
genet
suscept
ms
lhon
fact
small
subgroup
ms
patient
usual
promin
optic
neuriti
may
carri
pathogen
lhon
mutat
overlap
two
diseas
may
relat
associ
ms
mtdna
haplotyp
set
mtdna
polymorph
within
pathogen
lhon
mutat
preferenti
occur
recent
studi
unrel
bulgarian
patient
rrm
randomli
select
healthi
individu
analyz
presenc
mtdna
polymorph
determin
major
european
haplogroup
well
three
secondari
lhon
mutat
restrict
enzym
analysi
use
screen
patient
control
common
haplogroupassoci
polymorph
show
chang
occur
ms
patient
similar
rate
control
subject
howev
patient
posit
mutat
control
carri
mutat
p
b
suggest
base
substitut
may
predispos
marker
ms
find
also
support
hypothesi
particular
mtdna
variant
may
contribut
genet
suscept
peopl
ms
studi
relationship
lhon
ms
hwang
et
al
test
korean
ms
patient
presenc
mtdna
mutat
nucleotid
nt
nt
howev
none
ms
patient
exhibit
pathogen
lhon
mtdna
mutat
result
agreement
japanes
ms
patient
may
case
racial
characterist
may
influenc
associ
mitochondri
abnorm
patient
multipl
sclerosi
eae
mous
model
base
current
research
propos
mitochondri
abnorm
involv
develop
progress
multipl
sclerosi
includ
mitochondri
dna
defect
abnorm
mitochondri
gene
express
defect
mitochondri
enzym
activ
abnorm
defici
mitochondri
dna
repair
mechan
mitochondri
dysfunct
propos
abnorm
mitochondri
dynam
imbal
mitochondri
fission
fusion
play
key
role
tissu
affect
multipl
sclerosi
also
propos
mitochondri
abnorm
mitochondri
energi
failur
may
impact
cellular
pathway
includ
increas
demyelin
inflamm
neuron
tissu
affect
multipl
sclerosi
increas
evid
suggest
mitochondri
dysfunct
involv
ms
ultrastructur
analysi
demyelin
spinal
cord
lesion
show
dramat
reduc
number
mitochondria
microtubul
demonstr
ca
mediat
destruct
chronic
demyelin
axon
axon
swell
gene
express
studi
show
unbalanc
gene
express
ms
patient
reduc
energi
product
major
contributor
ca
mediat
axon
degener
author
focus
chang
oxid
phosphoryl
inhibitori
neurotransmiss
compar
control
transcript
decreas
increas
ms
cortex
twentysix
nuclearencod
mitochondri
gene
function
activ
mitochondri
respiratori
chain
complex
iii
decreas
ms
motor
cortex
reduc
mitochondri
gene
express
specif
neuron
addit
synapt
compon
gabaerg
neurotransmiss
densiti
inhibitori
interneuron
process
also
decreas
ms
cortex
addit
recent
number
mitochondri
respiratori
chain
protein
activ
lesion
acut
ms
analyz
use
immunohistochemistri
function
import
defect
mitochondri
respiratori
chain
complex
iv
cytochrom
c
oxidas
cox
includ
catalyt
compon
coxi
present
activ
ms
lesion
pattern
iii
lack
immunohistochem
detect
coxi
appar
oligodendrocyt
hypertrophi
astrocyt
axon
microglia
find
suggest
hypoxialik
tissu
injuri
pattern
iii
ms
lesion
may
initi
mitochondri
impair
hand
inact
area
chronic
ms
lesion
complex
iv
activ
mitochondri
mass
judg
porin
immunoreact
increas
within
approxim
half
larg
chronic
demyelin
axon
compar
larg
myelin
axon
brain
spinal
cord
axonspecif
mitochondri
dock
protein
syntaphilin
phosphoryl
neurofilamenth
increas
chronic
lesion
result
clearli
indic
adapt
chang
mitochondri
function
morpholog
chronic
ms
recent
regenold
et
al
investig
relationship
disturb
cn
mitochondri
energi
metabol
ms
diseas
progress
measur
cerebrospin
fluid
csf
concentr
sorbitol
fructos
lactat
metabolit
extramitochondri
glucos
metabol
found
concentr
three
metabolit
concentr
glucos
myoinositol
significantli
increas
csf
secondari
progress
lesser
degre
relapsingremit
patient
compar
healthi
control
furthermor
csf
concentr
sorbitol
fructos
polyol
pathway
metabolit
lactat
anaerob
glycolysi
metabolit
correl
posit
significantli
expand
disabl
statu
scale
edss
score
index
neurolog
disabl
ms
patient
find
suggest
abnorm
mitochondri
glucos
metabol
increas
ms
patient
associ
diseas
progress
interestingli
analysi
mitochondri
enzym
human
muscl
show
peopl
ms
fewer
type
fiber
fiber
type
smaller
lower
succin
dehydrogenas
sdh
compon
respiratori
chain
complex
ii
sdhalphaglycerolphosph
dehydrogenas
gpdh
gpdh
activ
suggest
muscl
diseas
smaller
reli
anaerob
aerobicoxid
energi
suppli
muscl
healthi
individu
similar
brain
muscl
also
highli
depend
mitochondri
oxid
energi
metabol
reason
weaker
muscl
ms
patient
indic
muscl
also
one
target
ms
rare
case
ms
could
mitochondri
myopathi
combin
mri
show
widespread
white
matter
lesion
muscl
biopsi
show
rag
red
fibr
cox
complex
iv
defici
southern
blot
analysi
reveal
larg
delet
mtdna
probabl
sever
mitochondri
genom
delet
key
caus
initi
factor
special
case
anoth
interest
key
issu
mitochondria
must
discuss
mitochondri
permeabl
transit
lead
mitochondri
swell
outer
membran
ruptur
releas
apoptot
mediat
mitochondri
permeabl
transit
pore
ptp
thought
consist
adenin
nucleotid
transloc
voltagedepend
anion
channel
cyclophilin
cypd
ppif
gene
product
prolyl
isomeras
locat
within
mitochondri
matrix
cypd
key
regul
ptp
requir
mediat
ca
oxid
damageinduc
cell
death
experiment
anim
ms
diseas
model
eae
mice
lack
cypd
show
neuron
miss
cypd
resist
oxid
agent
thought
mediat
axon
degener
observ
eae
ms
mitochondria
abl
effect
handl
elev
ca
consist
neuron
resist
anim
miss
cypd
abl
recov
clinic
follow
induct
eae
result
directli
implic
patholog
activ
mitochondri
ptp
axon
damag
occur
ms
word
ptp
mitochondria
critic
target
eae
perhap
multipl
sclerosi
reactiv
oxygen
speci
ro
byproduct
cellular
metabol
excess
ro
imbal
cellular
product
ro
abil
cell
defend
refer
oxid
stress
oxid
stress
caus
cellular
damag
subsequ
cell
death
ro
oxid
critic
cellular
compon
lipid
protein
dna
especi
mitochondri
dna
neurodegen
neuroinflammatori
disord
evid
primari
contribut
oxid
stress
neuron
death
oppos
diseas
oxid
stress
like
play
secondari
bystand
role
increas
evid
oxid
stress
import
compon
pathogenesi
ms
inflammatori
environ
demyelin
lesion
conduc
gener
reactiv
oxygen
speci
macrophag
microglia
known
express
myeloperoxidas
mpo
gener
ro
myelin
phagocytosi
white
matter
recent
research
involv
cerebr
cortex
ms
indic
microgli
product
ro
also
like
involv
cortic
demyelin
protein
kinas
c
pkc
could
induc
increas
product
ro
mononuclear
cell
patient
ms
compar
control
predominantli
exclus
gener
pkc
activ
nadph
oxidas
concentr
reactiv
oxygen
andor
nitrogen
speci
eg
superoxid
nitric
oxid
peroxynitrit
increas
dramat
condit
inflamm
overwhelm
inher
antioxid
defenc
within
lesion
oxid
andor
nitr
stress
damag
lipid
protein
nucleic
acid
cell
mitochondria
potenti
caus
cell
death
oligodendrocyt
sensit
oxid
nitr
stress
vitro
astrocyt
microglia
seemingli
due
diminish
capac
antioxid
defenc
presenc
rais
risk
factor
oxid
nitr
stress
might
therefor
result
select
oligodendrocyt
death
therebi
demyelin
vivo
reactiv
speci
may
also
damag
myelin
sheath
promot
attack
macrophagesmicroglia
evid
exist
oxid
nitr
stress
within
inflammatori
demyelin
lesion
includ
presenc
lipid
peroxid
protein
peroxid
protein
carbonyl
nitrotyrosin
marker
peroxynitrit
format
rosrn
gener
ms
anim
model
ms
product
superoxid
peroxynitrit
form
highli
toxic
glia
neuron
cell
kalman
group
determin
level
dna
damag
ms
patient
use
oxid
marker
found
signific
increas
dna
oxid
within
plaqu
compar
nawm
specimen
ms
cerebella
tendenc
increas
oxid
marker
normalappear
cortic
tissu
locat
proxim
ms
plaqu
also
observ
compar
control
cortic
specimen
also
oxid
damag
mitochondri
dna
impair
activ
mitochondri
enzym
complex
ms
lesion
suggest
inflamm
affect
energi
metabol
atp
synthesi
viabil
affect
cell
recent
report
show
oxid
stress
occur
progress
well
benign
ms
patient
exampl
serum
dien
conjug
level
measur
lipid
peroxid
significantli
elev
ms
patient
especi
patient
primari
progress
phenotyp
howev
serum
total
antioxid
activ
total
antirad
activ
differ
ms
patient
healthi
control
hand
chemic
composit
human
cerebrospin
fluid
consid
reflect
brain
metabol
experiment
evid
decreas
sulfhydryl
group
antioxid
increas
content
product
lipid
peroxid
ultraweak
chemiluminesc
liposolubl
fluoresc
higher
csf
plasma
ms
patient
control
clearli
point
role
oxid
stress
pathogenesi
ms
recent
insight
molecular
pathogenesi
progress
ms
also
list
oxid
stress
one
main
mechan
recent
van
horssen
j
et
al
report
presenc
extens
oxid
damag
protein
lipid
nucleotid
occur
activ
demyelin
ms
lesion
predominantli
reactiv
astrocyt
myelinladen
macrophag
reason
structurallydamag
myelin
protein
target
immun
system
recogn
foreign
antigen
henc
consid
leas
ms
patient
oxid
stress
includ
nitr
stress
may
primari
mechan
pathogenesi
hand
antioxid
enzym
includ
superoxid
dismutas
catalas
heme
oxygenas
markedli
upregul
activ
demyelin
ms
lesion
compar
normalappear
white
matter
white
matter
tissu
nonneurolog
control
brain
enhanc
antioxid
enzym
product
inflammatori
ms
lesion
may
reflect
adapt
defenc
mechan
reduc
rosinduc
cellular
damag
data
observ
strongli
indic
antioxid
therapi
may
potenti
treatment
ms
patient
describ
human
blood
macrophag
astrocyt
microgli
cell
make
present
increas
concentr
acut
ms
lesion
known
deleteri
effect
mitochondria
relationship
cytochrom
c
oxidas
mt
complex
iv
investig
differ
integr
level
enzym
includ
situ
state
mous
liver
mitochondria
cultur
human
neuroblastoma
cell
micromolar
rapidli
inhibit
cytochrom
c
oxidas
turnov
physiolog
substrat
respiratori
chain
inhibit
either
suppli
exogen
produc
endogen
via
synthas
activ
inhibit
respir
revers
although
remain
clarifi
whether
revers
alway
full
depend
concentr
time
exposur
least
hypox
condit
irrevers
inhibit
cytochrom
oxidas
superoxid
radic
combin
form
peroxynitr
onoo
break
form
highli
reactiv
radic
hydroxyl
radic
nitrogen
dioxid
word
enhanc
cellular
toxic
ro
peroxynitrit
reactiv
nitrogen
oxid
speci
exert
toxic
effect
neuron
axon
glia
cell
enhanc
apoptosi
addit
increas
bloodbrain
barrier
bbb
permeabl
therefor
promot
invas
inflammatori
cell
cn
hand
uric
acid
purin
metabolit
peroxynitrit
scaveng
inhibit
bloodcnsbarri
permeabl
chang
cn
inflamm
tissu
damag
eae
mice
spinal
cord
injuri
recent
concentr
uric
acid
purin
profil
creatinin
sampl
cerebrospin
fluid
serum
ms
patient
measur
detail
hplc
valu
compound
assay
significantli
higher
biolog
fluid
ms
patient
respect
valu
measur
control
particular
serum
hypoxanthin
xanthin
uric
acid
sum
oxypurin
respect
higher
patient
correspond
valu
record
control
though
differ
previous
report
data
clearli
demonstr
purin
compound
includ
uric
acid
elev
biolog
fluid
ms
patient
reinforc
trend
observ
creatinin
corrobor
notion
sustain
purin
catabol
possibl
due
imbal
atp
homeostasi
patholog
condit
observ
patholog
state
uric
acid
purin
compound
creatinin
consid
marker
metabol
energi
imbal
rather
reactiv
oxygen
speci
even
ms
nitric
oxid
synthas
no
also
play
import
role
physiolog
well
patholog
condit
activ
ino
enzym
demonstr
astrocyt
acut
chronic
activ
ms
lesion
lesion
edg
de
myelin
occur
qrtpcr
analysi
detect
signific
upregul
neuron
form
no
nno
ms
normalappear
white
matter
tissu
sampl
chang
togeth
upregul
oligodendrocyt
neuron
support
view
oligodendrocyt
andor
neuron
dysfunct
nonles
contain
tissu
possibl
primari
caus
major
develop
past
decad
ms
chang
untreat
treatabl
diseas
four
immunomodulatori
treatment
glatiram
acet
three
interferonb
prepar
two
immunosuppress
natalizumab
mitoxantron
approv
treatment
ms
allow
frequenc
attack
diminish
progress
disabl
slow
least
shorten
mediumterm
addit
number
new
strategi
develop
treatment
diseas
novel
immunomodul
includ
antibodiesimmunosuppress
therapeut
strategi
target
leukocyt
differenti
molecul
costimulatori
molecul
antiadhes
molecul
chemotaxi
autolog
stem
cell
transplant
antiinfecti
therapi
strategi
neuroprotect
neurorepair
remyelin
detail
see
previou
review
furthermor
good
scientif
rational
use
combin
therapi
ms
clinic
trial
also
current
underway
establish
therapeut
efficaci
safeti
variou
combin
therapi
ms
patient
recent
small
scale
openlabel
trial
combin
therapi
intramuscular
interferon
oral
doxycyclin
potent
inhibitor
matrix
metalloproteinas
patient
rrm
success
complet
combin
doxycyclin
interferon
treatment
result
reduct
contrastenhanc
lesion
number
posttreat
expand
disabl
statu
scale
valu
p
b
total
combin
treatment
effect
safe
well
toler
evalu
efficaci
toler
combin
import
work
doubleblind
random
placebocontrol
clinic
trial
larger
cohort
patient
ms
hope
trial
may
encourag
relat
reason
combin
studi
near
futur
eae
anim
model
novel
combin
cocktail
therapi
studi
alreadi
show
therapeut
efficaci
instanc
multipl
ag
peptid
map
contain
plp
peptid
arrang
around
dendrimer
branch
lysin
core
test
influenc
express
develop
relaps
eae
sjl
mice
plp
map
effici
agent
prevent
develop
clinic
diseas
administ
immun
treatment
effect
map
peptid
specif
long
last
observ
period
effect
cocktail
agent
test
differ
eae
model
includ
nonhuman
primat
model
prior
clinic
patient
trial
henc
evalu
specif
combin
therapi
control
set
preclin
studi
clinic
trial
prioriti
ms
research
ms
chronic
unpredict
neurolog
diseas
mainli
affect
cn
known
cure
mani
peopl
ms
often
seek
complementari
altern
medicin
cam
therapi
manag
diseas
symptom
result
literatur
show
around
peopl
ms
report
use
one
cam
therapi
major
reason
choos
cam
follow
convent
treatment
effect
anecdot
report
cam
help
doctor
referr
common
cam
therapi
peopl
use
includ
dietari
modif
nutrit
herbal
supplement
mindbodi
therapi
includ
acupunctur
massag
reviv
interest
among
ms
research
therapeut
potenti
lowfat
diet
essenti
fatti
acid
supplement
ms
efficaci
specif
vitamin
supplement
remain
unclear
recent
cannabi
yoga
studi
control
studi
provid
evid
may
benefit
research
cam
therapi
ms
still
exploratori
consid
peopl
interest
common
use
therapi
research
area
clearli
warrant
tradit
chines
medicin
tcm
intrins
system
treatment
patient
use
sever
thousand
year
today
still
import
part
medicin
china
interestingli
journal
integr
chines
medicin
western
medicin
show
ms
patient
could
divid
two
main
type
syndrom
type
accord
clinic
manifest
ganshen
yindefici
gsyd
type
yinyang
defici
yyd
type
found
age
first
attack
later
level
mbp
cerebrospin
fluid
higher
yyd
type
gsyd
type
besid
relaps
time
gsyd
type
bloodbrain
barrier
index
level
mbp
yyd
type
show
ascend
trend
p
respect
distinguish
classif
patient
ms
first
step
treatment
patient
diseas
use
tcm
howev
import
issu
random
wellcontrol
clinic
trial
ms
patient
difficult
task
complet
soon
possibl
hand
exist
immunolog
differ
ms
patient
gsyd
type
yyd
type
indic
tradit
chines
medicin
scientif
basi
even
fulli
understood
recent
iranian
herbalmarin
medicin
report
amelior
experiment
allerg
encephalomyel
mice
henc
cam
explor
basic
clinic
studi
wide
perform
would
expect
provid
use
therapeut
agent
treatment
ms
patient
describ
multipl
sclerosi
complex
consid
autoimmun
neurodegen
diseas
current
treatment
ms
includ
immunomodulatori
agent
neuroprotect
regen
therapi
avail
especi
patient
ms
respond
well
treatment
agent
variou
anim
model
learn
remyelin
cn
potent
neuroprotect
mechan
knowledg
oligodendrocyt
biolog
process
remyelin
greatli
increas
recent
year
howev
precis
mechan
far
understood
remyelin
neurogener
well
neuroprotect
occur
anim
model
although
remyelin
principl
also
possibl
diseas
ms
brain
clear
fail
mani
ms
patient
clinic
trial
perform
far
either
fail
show
effect
insuffici
design
thu
knowledg
molecular
mechan
repair
process
ms
pathophysiolog
requir
achiev
ultim
goal
neuroprotect
neuroregen
treatment
ms
describ
cypd
knockout
mous
studi
provid
evid
direct
link
mitochondri
function
ca
overload
axon
destruct
eae
extens
ms
henc
compound
abl
inhibit
ptp
inactiv
cypd
specif
mechan
modul
ptp
would
seem
warrant
investig
neuroprotect
therapi
ms
intraven
mitoxantron
novantron
treatment
improv
neurolog
disabl
delay
progress
ms
patient
worsen
relapsingremit
secondari
progress
diseas
regard
action
mechan
approv
immunosuppress
mitoxantron
synthet
analog
anthraquinon
least
tumor
cell
mitochondri
ptp
target
mechan
involv
mitochondri
dna
repair
new
import
part
neuroprotect
age
relat
diseas
includ
ms
multipl
pathway
dna
repair
elucid
nuclear
dna
howev
appear
base
excis
repair
function
mitochondria
repair
pathway
respons
remov
endogen
damag
includ
alkyl
damag
oxid
damag
interestingli
astrocyt
exhibit
effici
repair
wherea
glial
cell
type
neuron
cell
exhibit
reduc
abil
remov
lesion
mtdna
strategi
target
dna
repair
protein
mitochondria
enhanc
mtdna
repair
capac
develop
enhanc
mtdna
repair
oligodendrocyt
provid
protect
reactiv
oxygen
speciesand
cytokineinduc
apoptosi
experi
provid
novel
strategi
protect
sensit
cn
cell
thu
provid
new
treatment
option
neurodegen
diseas
ms
describ
patholog
section
ion
channel
ionic
imbal
involv
ms
initi
develop
channel
blocker
protect
axon
inflammatori
mediat
fact
na
channel
blocker
tetrodotoxin
block
na
influx
throughout
anox
period
shown
preserv
atp
level
concurr
protect
white
matter
axon
noinduc
injuri
anoth
na
channel
blocker
phenytoin
flecainid
shown
protect
mous
rat
model
eae
protect
effect
axon
clinic
improv
persist
long
day
mice
treat
regularli
phenytoin
neurotroph
factor
insulinlik
growth
factori
plateletderiv
growth
factor
pdgf
fibroblast
growth
factor
ciliari
neurotroph
factor
cntf
multifunct
growth
factor
found
cn
vitro
vivo
studi
shown
neurotroph
factor
influenc
prolifer
differenti
surviv
regener
matur
oligodendrocyt
oligodendrogli
precursor
favor
myelin
repair
sinc
myelin
breakdown
often
sever
ms
possibl
growth
factor
use
treatment
ms
consid
recent
shown
reduc
lesion
sever
promot
myelin
regener
eae
investig
role
endogen
cntf
inflammatori
demyelin
diseas
moginduc
eae
cntfdefici
wildtyp
mice
studi
diseas
sever
cntfdefici
mice
recoveri
poor
decreas
number
prolifer
oligodendrocyt
precursor
cell
increas
rate
oligodendrocyt
apoptosi
addit
vacuolar
dystrophi
myelin
axon
damag
sever
cntfdefici
mice
specif
patholog
featur
could
prevent
treatment
antiserum
tumor
necrosi
factoralpha
suggest
endogen
cntf
may
counterbal
effect
henc
cntf
modul
inflammatori
environ
glial
cell
surviv
outcom
determin
eae
may
hope
agent
treatment
ms
patient
recent
neuroprotect
role
ctnf
confirm
overexpress
cntf
eae
mice
possibl
exert
immunoregulatori
activ
inhibit
inflamm
reduc
demyelin
stimul
oligodendrogenesi
oligodendroglia
cell
form
maintain
myelin
sheath
oligodendrogli
lineag
target
approach
would
interest
notabl
remyelin
regul
stimul
inhibitor
leucinerich
repeat
ig
domaincontain
neurit
outgrowth
inhibitor
receptorinteract
potent
neg
regul
axon
myelin
loss
function
gene
knockout
treatment
antibodi
antagonist
function
lead
function
recoveri
eae
remyelin
role
associ
enhanc
opc
differenti
therefor
antagon
pathway
promis
approach
treatment
ms
sinc
oxid
damag
known
involv
inflammatori
autoimmunemedi
tissu
destruct
modul
oxygen
free
radic
product
repres
new
approach
treatment
inflammatori
autoimmun
diseas
although
antioxid
show
efficaci
anim
model
limit
conflict
evid
potenti
therapeut
effect
antioxid
vitamin
c
e
treat
ms
otherwis
littl
inform
avail
effect
treatment
antioxid
patient
ms
initi
phase
ms
lesion
format
ro
known
mediat
transendotheli
migrat
monocyt
induc
dysfunct
bbb
benefici
effect
antioxid
alphalipo
acid
la
phenomena
investig
interestingli
la
dosedepend
prevent
develop
clinic
sign
rat
model
ms
clinic
improv
coupl
decreas
leukocyt
infiltr
cn
particular
monocyt
live
cell
imag
assess
ro
produc
within
minut
upon
interact
monocyt
brain
endothelium
monocyt
adhes
vitro
model
bbb
subsequ
induc
enhanc
permeabl
could
inhibit
la
henc
la
protect
effect
eae
affect
migratori
capac
monocyt
also
stabil
bbb
make
la
attract
therapeut
agent
treatment
ms
discuss
mitochondrialtarget
antioxid
particularli
mitoq
cart
may
potenti
role
eae
model
ms
diseas
recent
discov
potenti
direct
interact
neuropeptid
cart
subunit
b
mitochondri
enzym
succin
dehydrogenas
sdhb
found
cart
significantli
increas
sdh
function
mt
complex
ii
activ
atp
gener
purifi
mitochondria
primari
cultur
neuron
furthermor
pretreat
cart
enhanc
mitochondri
mechan
neuron
surviv
prevent
declin
sdh
cii
activ
atp
product
ogd
find
suggest
cart
neuroprotect
mechan
action
may
link
preserv
mitochondri
function
prevent
energi
failur
ischemiareperfus
injuri
importantli
cart
transcript
activ
stimul
brainderiv
neurotroph
factor
product
cultur
neuron
cell
recent
found
cart
protect
role
mous
eae
model
unpublish
data
observ
indic
mitochondrialtarget
neuroprotect
benefit
eae
probabl
ms
patient
doubleblind
placebocontrol
parallel
group
design
clinic
trial
effect
ginkgo
biloba
popular
herbal
medicin
china
japan
function
measur
ms
complet
ginkgo
group
patient
receiv
mg
per
day
ginkgo
special
extract
egb
significantli
individu
show
improv
four
measur
improv
associ
significantli
larger
effect
size
measur
fatigu
symptom
sever
function
ginkgo
group
also
exhibit
less
fatigu
followup
compar
placebo
group
exploratori
pilot
studi
also
show
advers
event
side
effect
report
therefor
ginkgo
exert
modest
benefici
effect
select
function
measur
eg
fatigu
among
individu
ms
even
though
studi
may
need
verif
multiplecent
larg
scale
studi
excit
function
data
indic
cam
tradit
medicin
worth
explor
treatment
ms
well
relat
diseas
summari
ms
complic
autoimmun
neurodegen
diseas
causal
factor
still
unknown
sever
cellular
mechan
propos
includ
genet
factor
viral
infect
autoimmun
attack
demyelin
mitochondri
dysfunct
free
radic
product
ionic
imbal
cellular
clearanc
system
dysfunct
lead
final
neuron
loss
factor
work
either
primari
caus
secondari
consequ
howev
mani
case
work
togeth
caus
ms
diseas
ongo
effort
across
world
search
genet
loci
may
caus
vast
major
patient
ms
may
provid
import
clue
understand
diseas
process
given
central
role
mitochondria
mani
import
cellular
function
includ
energi
product
reason
dysfunct
key
contributor
neurodegen
process
diseas
propos
inflamm
may
initi
infect
intrins
imbal
cellular
energi
failur
increas
oxid
stress
neuron
oligodendrocyt
tissu
respons
inflamm
control
dna
defect
nuclear
mitochondri
genom
ms
patient
therefor
mitochondrialtarget
neuroprotect
treatment
combin
neuroprotect
immunomodulatori
may
repres
new
correct
approach
ms
therapi
